Canaccord analyst Richard Close lowered the firm’s price target on HealthStream (HSTM) to $29 from $30 and keeps a Hold rating on the shares. The firm said they reported 1Q’25 results which fell below Canaccord and consensus estimates as well as a reduction in 2025 guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSTM: